8 posts in this category
Novo Nordisk and Hims struck a deal on Ozempic and Wegovy pricing. See what it means for GLP-1 costs, compounded access, and your options.
GLP-1 shots cost under $5 to make but sell for $900+. See what drives the price, whether it's justified, and how pricing is changing in 2026.
India’s GLP-1 patent expiry may lower prices there first. Learn what it could mean for US access and affordability.
Major GLP-1 and obesity drug trials are finishing in 2027. Here’s what they’re studying and what it could mean for access and affordability.
Latest updates on Indiana, Florida, and federal GLP-1 compounding laws and what the changes could mean for patient access in 2026.
High cost and poor coverage make people stop GLP-1s early, reducing benefits and adherence.
We’re working hard to keep things updated but give us some grace to work with providers who are potentially changing their offerings around tirzepatide.
I want to challenge Hims… Why do you advertise and encourage patients who are new to this medication to buy 12 months upfront?
